Cerebral hemodynamic and metabolic alterations in hypovolemic shock.
D000344:Afferent Pathways; D000818:Animals; D001794:Blood Pressure; D001921:Brain / Q000098:blood supply / Q000503:physiopathology*; D002302:Cardiac Output; D003847:Deoxyglucose / Q000378:metabolism; D004558:Electric Stimulation; D004569:Electroencephalography; D006863:Hydrogen-Ion Concentration; D007031:Hypothalamus / Q000098:blood supply; D007773:Lactates / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D010100:Oxygen / Q000502:physiology; D010101:Oxygen Consumption; D010643:Phenoxybenzamine / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D012769:Shock / Q000503:physiopathology*; D013788:Thalamus / Q000098:blood supply; D014655:Vascular Resistance; D014666:Vasomotor System / Q000503:physiopathology
D007773:Lactates; D010643:Phenoxybenzamine; D009243:NAD; D003847:Deoxyglucose; D010100:Oxygen